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Dr. Iona Heath, former President of the Royal College of General Practitioners, asked the medical profession to rise
to the âchallenge of multimorbidityâ
1
. Heath argued for the ânecessary paradigm shift from a disease based model
of care to one that focuses on care for patientsâ and to move away from single-disease focused guidelines, which
silo patients inappropriately. Multimorbidity is defined as the co-existence of two of more chronic illnesses within
the same patient
2
. We know that multimorbidity is very common- half of all patients over 65 will have at least three
coexisting diseases, with 20% having over five
3
.
With a proposed radical overhaul of Irish general practice rapidly approaching, including
free-at-the-point-of-delivery universal access, what is our knowledge about how such changes will affect care
provision? Associate Professor Susan Smith recently concluded in a meta-analysis âevidence on the care of patients
with multimorbidity is limited, despite the prevalence of multimorbidity and its impact on patients and healthcare
systems.â
3
 There is little current evidence on what effects universal access to Irish primary care will have on
workload, health utilisation and outcomes for âreal-worldâ multimorbid patients.
We simply looked at health utilisation rates between GMS and non-GMS eligible patients in two chronic conditions, in a
multimorbid population. We looked at 7,213 patients from the CLARITY database, all of whom had established heart
disease. This was designed to research a multimorbid cardiovascular population, including patients aged over 50 years,
who had two or more consultations over the previous two years, selected from 67,422 patients within 11 practices in
the West of Ireland. We found that multimorbid asthma patients, with GMS eligibility, had significantly more primary
care visits per annum than non-GMS patients, after modelling for confounding variables such as age, gender and
smoking. GMS asthma patients had a mean of 10.7 consultations annually (95% CI 9.9 to 11.5) and non-GMS had a mean of
5.1 consultations (95% CI 4.2 to 6.1). Similarly, multimorbid COPD patients that were GMS eligible had significantly
more primary care visits per annum than non-GMS patients. GMS COPD patients had a mean of 11.4 consultations annually
(95% CI 10.4 to 12.4) compared to non-GMS having a mean of 6.6 consultations (95% CI 4.0 to 9.1).
We believe the provision of universal entitlement to primary care could result in three distinct outcomes, or a
complex combination of all three. Firstly, utilisation rates for those who currently do not have GMS eligibility could
increase to the levels of those currently with GMS eligibility. Alternatively, GMS-eligible patients could continue to
have higher healthcare usage, albeit relatively lower than before. Finally, and least likely, no changes in
utilisation may occur. What is clear is that further research needs to be performed regarding multimorbid patients in
the community, so that evidence based policy is possible.
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